| Name: | Transcept Pharmaceuticals, Inc. |
| Jurisdiction: | Alaska |
| Legal type: | Business Corporation |
| Status: | Revoked |
| Date of registration: | 31 Mar 2009 (16 years ago) |
| Entity Number: | 122397 |
| Place of Formation: | DELAWARE |
| Mailing Address: | 1003 W. Cutting Blvd., Suite 110, RICHMOND, CA 94804 |
| Name | Role | Shares |
|---|---|---|
| C T Corporation System | Registered Agent | - |
| Glenn A Oclassen | Director, President | - |
| Hamilton Bio Ventures | Shareholder | 6.58 |
| InterWest Partners, LLC | Shareholder | 8.26 |
| Joseph T Kennedy | Secretary | - |
| Montreux Equity Partners | Shareholder | 8.83 |
| New Enterprise Associates | Shareholder | 14.10 |
| New Leaf Venture Partners | Shareholder | 10.81 |
| Nikhilesh N Singh | Director | - |
| Thomas P Soloway | Vice President | - |
Date of last update: 12 Feb 2025
Sources: State of Alaska - Department of Commerce, Community, and Economic Development
